Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: Effect of labetalol

Experimental Neurology

Volumn 150, Issue 1, 1998, Pages 153-158

  Fagan, Susan C ^a   Bowes, Mark P ^b   Lyden, Patrick D ^b   Zivin, Justin A ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral hemorrhage; Embolic stroke; Labetalol; Rabbit

Indexed keywords

ANGIOTENSIN; LABETALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN HEMORRHAGE; CONTROLLED STUDY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STROKE;

EID: 0032032596     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6756     Document Type: Article

References (18)

1. Hommel M., Boissel J. P., Cornu C., Boutitie F., Lees K. R., Besson G., Leys D., Amarenco P., Bogaert M. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet. 345:1995;57.
2. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Hoxter G., Mahagne M. H., Hennerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. J. Am. Med. Assoc. 274:1995;1017-1025.
3. Lancet. 346:1995;1509-1514.
4. N. Engl. J. Med. 333:1995;1581-1587.
5. Donnan G. A., Davis S. M., Chambers B. R., Gates P. C., Hanckey G. J., McNeill J. J. Streptokinase for acute ischemic stroke with relationship to time of administration. J. Am. Med. Assoc. 276:1996;961-966.
6. Hornig C. R., Bauer T., Simon C., Trittmacher S., Dorndorf W. Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke. 24:1993;465-468.
7. Moulin T., Crepin-Leblond T., Chopard J. L., Bogousslavsky J. Hemorrhagic infarcts. Eur. Neurol. 34:1993;64-77.
8. Beghi E., Bogliun G., Cavaletti G., Sangi I., Tagliabue M., Agostoni F., Macchi I. Hemorrhagic infarction: Risk factors, clinical and tomographic features, and outcome. Acta Neurol. Scand. 80:1989;226-223.
9. Giroud M., Creisson E., Fayolle H., Andre N., Becker F., Martin D., Dumas R. Risk Factors for Primary Cerebral Hemorrhage: A Population-Based Study-the Stroke Registry of Dijon. Neuroepidemiology. 14:1995;20-26.
10. Powers W. J. Acute hypertension after stroke: The scientific basis for treatment decisions. Neurology. 43:1993;461-467.
11. Spence J. D., Del Maestro R. F. Hypertension in Acute Ischemic Strokes. Arch. Neurol. 42:1985;1000-1002.
12. Yatsu F. M., Zivin J. A. Hypertension in acute ischemic strokes: Not to treat. Arch. Neurol. 42:1985;999-1000.
13. Bowes M. P., Thomas G. R., Thibodeaux H., Fagan S. C., Zivin J. A. Acute hypertension, but not thrombolysis, increases the incidence and severity of cerebral hemorrhage in rabbits. Exp. Neurol. 141:1996;40-46.
14. Puchstein C., Van Aken H., Hidding J., Anger C., Lawin P. Treatment of hypertension with labetalol in neurosurgical practice: Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions. Acta Neurochir. 67:1983;283-290.
15. Adams H. P., Brott T. G., Furlan A. J., Gomez C. R., Grotta J., Helgason C. M., Kwiatkowski T., Lyden P. D., Marler J. R., Torner J., Feinberg W., Mayberg M., Thies W. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 27:1996;1711-1718.
16. Carter L. P., Guthkelch A. N., Orozco J., Temeltas O. Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model. Stroke. 23:1992;883-888.
17. Cohen, J. 1969, Statistical Power Analysis for the Behavioral Sciences, Academic Press, New York.
18. Saku Y., Choki J., Waki R., Masuda J., Tamaki K., Fujishima M., Ogata J. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke. 21:1990;589-595.